LB-1(Centessa Pharmaceuticals)

N/A

Report date: 2023/02/19 23:42:27
NME

Base Information

Drug NameLB-1(Centessa Pharmaceuticals)
Drug Alias NameLB-1
ClassificationSmall molecules
Mechanisms of ActionCluster of differentiation 47 inhibitorsCD8-positive T-Lymphocytes stimulantsProgrammed death-ligand 1 blockers
TargetsCluster of differentiation 47Programmed death-ligand 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLockbody Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLockbody Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A